Literature DB >> 8848947

The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey.

P D McGorry1, C McFarlane, G C Patton, R Bell, M E Hibbert, H J Jackson, G Bowes.   

Abstract

In most cases of schizophrenia the onset of frank psychosis is preceded by a period of prodromal features. This period has been relatively neglected by researchers and is potentially important in promoting early intervention. The prevalence of DSM-III-R schizophrenia prodrome symptoms was assessed as part (n = 657) of a large (n = 2525) questionnaire-based survey of high school students. Individual symptoms were highly prevalent and the prevalence of DSM-III-R prodromes ranged from 10 - 15% to 50%. Despite methodological weaknesses, the data suggest that DSM-III-R prodromal features are extremely prevalent among older adolescents and unlikely to be specific for subsequent schizophrenia. Clinically these features cannot be regarded as sufficient evidence of early schizophrenia and more accurate predictors of incipient schizophrenia need to be defined.

Entities:  

Mesh:

Year:  1995        PMID: 8848947     DOI: 10.1111/j.1600-0447.1995.tb09577.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  29 in total

1.  PROD-screen--a screen for prodromal symptoms of psychosis.

Authors:  M Heinimaa; R K R Salokangas; T Ristkari; M Plathin; J Huttunen; T Ilonen; T Suomela; J Korkeila; T H McGlashan
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 2.  The development of schizophrenia in late adolescence.

Authors:  Chris E Harrop
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

Review 3.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

4.  Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective.

Authors:  Vijay A Mittal; Derek J Dean; Jessica A Bernard; Joseph M Orr; Andrea Pelletier-Baldelli; Emily E Carol; Tina Gupta; Jessica Turner; Daniel R Leopold; Briana L Robustelli; Zachary B Millman
Journal:  Schizophr Bull       Date:  2013-12-27       Impact factor: 9.306

5.  Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology.

Authors:  Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun M Eack; Alan N Francis; Jean M Miewald; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

6.  A survey of psychosis risk symptoms in Kenya.

Authors:  Daniel Mamah; Anne Mbwayo; Victoria Mutiso; Deanna M Barch; John N Constantino; Thelma Nsofor; Lincoln Khasakhala; David M Ndetei
Journal:  Compr Psychiatry       Date:  2011-09-25       Impact factor: 3.735

7.  Associations between psychotic-like symptoms and inattention/hyperactivity symptoms.

Authors:  Tuula Marketta Hurtig; Anja Taanila; Juha Veijola; Hanna Ebeling; Pirjo Mäki; Jouko Miettunen; Marika Kaakinen; Matti Joukamaa; Sebastian Therman; Markus Heinimaa; Marjo-Riitta Järvelin; Irma Moilanen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

8.  A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.

Authors:  Judith Rietdijk; Sara Dragt; Rianne Klaassen; Helga Ising; Dorien Nieman; Lex Wunderink; Philippe Delespaul; Pim Cuijpers; Don Linszen; Mark van der Gaag
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

9.  Self-report of attenuated psychotic experiences in a college population.

Authors:  Rachel L Loewy; Jennifer K Johnson; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2007-04-24       Impact factor: 4.939

10.  Early intervention in schizophrenia.

Authors:  Parmanand Kulhara; Anindya Banerjee; Alakananda Dutt
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.